Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 457 articles:
HTML format
Text format



Single Articles


    January 2018
  1. MACIEL EMGS, Amancio JS, Castro DB, Braga JU, et al
    Social determinants of pulmonary tuberculosis treatment non-adherence in Rio de Janeiro, Brazil.
    PLoS One. 2018;13:e0190578.
    PubMed     Text format     Abstract available


  2. FELEKE BE, Alene GD, Feleke TE, Motebaynore Y, et al
    Clinical response of tuberculosis patients, a prospective cohort study.
    PLoS One. 2018;13:e0190207.
    PubMed     Text format     Abstract available


  3. LI J, Yip BHK, Leung C, Chung W, et al
    Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    PLoS One. 2018;13:e0189531.
    PubMed     Text format     Abstract available


  4. PARLATO S, Chiacchio T, Salerno D, Petrone L, et al
    Impaired IFN-alpha-mediated signal in dendritic cells differentiates active from latent tuberculosis.
    PLoS One. 2018;13:e0189477.
    PubMed     Text format     Abstract available


  5. HARRINGTON-KANDT R, Stylianou E, Eddowes LA, Lim PJ, et al
    Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model.
    PLoS One. 2018;13:e0191038.
    PubMed     Text format     Abstract available


  6. ABEBE F, Belay M, Legesse M, K L M C F, et al
    IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals.
    PLoS One. 2018;13:e0190989.
    PubMed     Text format     Abstract available


  7. MCCARTHY K, Fielding K, Churchyard GJ, Grant AD, et al
    Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests.
    PLoS One. 2018;13:e0191608.
    PubMed     Text format     Abstract available


  8. MUPFUMI L, Moyo S, Molebatsi K, Thami PK, et al
    Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
    PLoS One. 2018;13:e0192030.
    PubMed     Text format     Abstract available


  9. ZHU Z, Hao D, Wang B, Gao W, et al
    Selection of surgical treatment approaches for cervicothoracic spinal tuberculosis: A 10-year case review.
    PLoS One. 2018;13:e0192581.
    PubMed     Text format     Abstract available


  10. VEESA KS, John KR, Moonan PK, Kaliappan SP, et al
    Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
    PLoS One. 2018;13:e0191591.
    PubMed     Text format     Abstract available


  11. STOCKDALE L, Nash S, Nalwoga A, Painter H, et al
    Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.
    PLoS One. 2018;13:e0192086.
    PubMed     Text format     Abstract available


  12. UFIMTSEVA E, Eremeeva N, Petrunina E, Umpeleva T, et al
    Ex vivo expansion of alveolar macrophages with Mycobacterium tuberculosis from the resected lungs of patients with pulmonary tuberculosis.
    PLoS One. 2018;13:e0191918.
    PubMed     Text format     Abstract available


  13. TILAHUN M, Ameni G, Desta K, Zewude A, et al
    Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
    PLoS One. 2018;13:e0193083.
    PubMed     Text format     Abstract available


  14. KORTHALS ALTES H, Kloet S, Cobelens F, Bootsma M, et al
    Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling.
    PLoS One. 2018;13:e0192282.
    PubMed     Text format     Abstract available


  15. GAUTAM SS, Mac Aogain M, Cooley LA, Haug G, et al
    Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.
    PLoS One. 2018;13:e0192351.
    PubMed     Text format     Abstract available


  16. TIWARI V, Kedia S, Garg SK, Rampal R, et al
    CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
    PLoS One. 2018;13:e0193433.
    PubMed     Text format     Abstract available


  17. BISALLAH CI, Rampal L, Lye MS, Mohd Sidik S, et al
    Effectiveness of health education intervention in improving knowledge, attitude, and practices regarding Tuberculosis among HIV patients in General Hospital Minna, Nigeria - A randomized control trial.
    PLoS One. 2018;13:e0192276.
    PubMed     Text format     Abstract available


  18. DUDLEY L, Mukinda F, Dyers R, Marais F, et al
    Mind the gap! Risk factors for poor continuity of care of TB patients discharged from a hospital in the Western Cape, South Africa.
    PLoS One. 2018;13:e0190258.
    PubMed     Text format     Abstract available


  19. BOJOVIC O, Medenica M, Zivkovic D, Rakocevic B, et al
    Factors associated with patient and health system delays in diagnosis and treatment of tuberculosis in Montenegro, 2015-2016.
    PLoS One. 2018;13:e0193997.
    PubMed     Text format     Abstract available


  20. PEREIRA GR, Barbosa MS, Dias NJD, Almeida CPB, et al
    Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
    PLoS One. 2018;13:e0193988.
    PubMed     Text format     Abstract available


  21. BASTARD M, Sanchez-Padilla E, du Cros P, Khamraev AK, et al
    Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    PLoS One. 2018;13:e0193491.
    PubMed     Text format     Abstract available


  22. RIVIERE J, Le Strat Y, Hendrikx P, Dufour B, et al
    Perceptions and acceptability of some stakeholders about the bovine tuberculosis surveillance system for wildlife (Sylvatub) in France.
    PLoS One. 2018;13:e0194447.
    PubMed     Text format     Abstract available


  23. MUNRO-ROJAS D, Fernandez-Morales E, Zarrabal-Meza J, Martinez-Cazares MT, et al
    Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico.
    PLoS One. 2018;13:e0193626.
    PubMed     Text format     Abstract available


  24. LA MANNA MP, Orlando V, Li Donni P, Sireci G, et al
    Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    PLoS One. 2018;13:e0192664.
    PubMed     Text format     Abstract available


  25. BLANCO-GUILLOT F, Castaneda-Cediel ML, Cruz-Hervert P, Ferreyra-Reyes L, et al
    Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico.
    PLoS One. 2018;13:e0193911.
    PubMed     Text format     Abstract available


  26. DANGISSO MH, Woldesemayat EM, Datiko DG, Lindtjorn B, et al
    Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.
    PLoS One. 2018;13:e0193396.
    PubMed     Text format     Abstract available


  27. SEIPONE ID, Singh R, Patel VB, Singh A, et al
    Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides.
    PLoS One. 2018;13:e0192060.
    PubMed     Text format     Abstract available


  28. WANGARI IM, Stone L
    Backward bifurcation and hysteresis in models of recurrent tuberculosis.
    PLoS One. 2018;13:e0194256.
    PubMed     Text format     Abstract available


  29. ESHETIE S, Gizachew M, Alebel A, van Soolingen D, et al
    Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0194675.
    PubMed     Text format     Abstract available


  30. ASHHURST AS, Parumasivam T, Chan JGY, Lin LCW, et al
    PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0194620.
    PubMed     Text format     Abstract available


  31. STOCKBRIDGE EL, Miller TL, Carlson EK, Ho C, et al
    Private sector tuberculosis prevention in the US: Characteristics associated with interferon-gamma release assay or tuberculin skin testing.
    PLoS One. 2018;13:e0193432.
    PubMed     Text format     Abstract available


  32. TAKAKI K, Ramakrishnan L, Basu S
    A zebrafish model for ocular tuberculosis.
    PLoS One. 2018;13:e0194982.
    PubMed     Text format     Abstract available


  33. DENNIS EM, Hao Y, Tamambang M, Roshan TN, et al
    Tuberculosis during pregnancy in the United States: Racial/ethnic disparities in pregnancy complications and in-hospital death.
    PLoS One. 2018;13:e0194836.
    PubMed     Text format     Abstract available


  34. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0195409.
    PubMed     Text format     Abstract available


  35. KONIG WALLES J, Tesfaye F, Jansson M, Tolera Balcha T, et al
    Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    PLoS One. 2018;13:e0193589.
    PubMed     Text format     Abstract available


  36. JAJOU R, Neeling A, Hunen RV, Vries G, et al
    Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study.
    PLoS One. 2018;13:e0195413.
    PubMed     Text format     Abstract available


  37. QUAGLIO G, Pizzol D, Bortolani A, Manenti F, et al
    Breast tuberculosis in men: A systematic review.
    PLoS One. 2018;13:e0194766.
    PubMed     Text format     Abstract available


  38. PARMAR MM, Sachdeva KS, Dewan PK, Rade K, et al
    Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    PLoS One. 2018;13:e0193903.
    PubMed     Text format     Abstract available


  39. HUDSON M, Rutherford GW, Weiser S, Fair E, et al
    Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
    PLoS One. 2018;13:e0194960.
    PubMed     Text format     Abstract available


  40. CHAMIE G, Kato-Maeda M, Emperador DM, Wandera B, et al
    Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda.
    PLoS One. 2018;13:e0192666.
    PubMed     Text format     Abstract available


  41. SHEWADE HD, Kokane AM, Singh AR, Parmar M, et al
    Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    PLoS One. 2018;13:e0196162.
    PubMed     Text format     Abstract available


  42. HELLA J, Cercamondi CI, Mhimbira F, Sasamalo M, et al
    Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin.
    PLoS One. 2018;13:e0195985.
    PubMed     Text format     Abstract available


  43. DANGISSO MH, Woldesemayat EM, Datiko DG, Lindtjorn B, et al
    Correction: Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.
    PLoS One. 2018;13:e0196432.
    PubMed     Text format     Abstract available


  44. KIM SJ, Ye S, Ha E, Chun EM, et al
    Association of body mass index with incident tuberculosis in Korea.
    PLoS One. 2018;13:e0195104.
    PubMed     Text format     Abstract available


  45. WU W, Yang M, Xu M, Ding C, et al
    Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China.
    PLoS One. 2018;13:e0195695.
    PubMed     Text format     Abstract available


  46. LEUNG-THEUNG-LONG S, Coupet CA, Gouanvic M, Schmitt D, et al
    A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0196815.
    PubMed     Text format     Abstract available


  47. RENIER W, Bourdin A, Rubbo PA, Peries M, et al
    B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    PLoS One. 2018;13:e0196470.
    PubMed     Text format     Abstract available


  48. MANANA PN, Kuonza L, Musekiwa A, Koornhof H, et al
    Feasibility of using postal and web-based surveys to estimate the prevalence of tuberculosis among health care workers in South Africa.
    PLoS One. 2018;13:e0197022.
    PubMed     Text format     Abstract available


  49. PIENAAR E, Linderman JJ, Kirschner DE
    Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
    PLoS One. 2018;13:e0196322.
    PubMed     Text format     Abstract available


  50. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    PubMed     Text format     Abstract available


  51. JORSTAD MD, Marijani M, Dyrhol-Riise AM, Sviland L, et al
    MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar.
    PLoS One. 2018;13:e0196723.
    PubMed     Text format     Abstract available


  52. PADMASAWITRI TIA, Frederix GW, Alisjahbana B, Klungel O, et al
    Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
    PLoS One. 2018;13:e0193293.
    PubMed     Text format     Abstract available


  53. TSENG YL, Chang CC, Chen YY, Liu YS, et al
    From one incision to one port: The surgical technique and the evolution of segmentectomy in patients with pulmonary tuberculosis.
    PLoS One. 2018;13:e0197283.
    PubMed     Text format     Abstract available


  54. JAJOU R, de Neeling A, van Hunen R, de Vries G, et al
    Correction: Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study.
    PLoS One. 2018;13:e0197556.
    PubMed     Text format     Abstract available


  55. ORDONEZ AA, Pokkali S, Kim S, Carr B, et al
    Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
    PLoS One. 2018;13:e0197474.
    PubMed     Text format     Abstract available


  56. ALENE KA, Viney K, Yi H, McBryde ES, et al
    Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    PLoS One. 2018;13:e0197880.
    PubMed     Text format     Abstract available


  57. ATALELL KA, Birhan Tebeje N, Ekubagewargies DT
    Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    PLoS One. 2018;13:e0197145.
    PubMed     Text format     Abstract available


  58. NAHID P, Jarlsberg LG, Kato-Maeda M, Segal MR, et al
    Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.
    PLoS One. 2018;13:e0195392.
    PubMed     Text format     Abstract available


  59. RAIZADA N, Khaparde SD, Salhotra VS, Rao R, et al
    Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.
    PLoS One. 2018;13:e0193194.
    PubMed     Text format     Abstract available


  60. DELLA BELLA C, Spinicci M, Grassi A, Bartalesi F, et al
    Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
    PLoS One. 2018;13:e0197825.
    PubMed     Text format     Abstract available


  61. MUPFUMI L, Moyo S, Molebatsi K, Thami PK, et al
    Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
    PLoS One. 2018;13:e0198711.
    PubMed     Text format     Abstract available


  62. LI Y, Jia W, Lei G, Zhao D, et al
    Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.
    PLoS One. 2018;13:e0198600.
    PubMed     Text format     Abstract available


  63. DEKHIL N, Skhairia MA, Mhenni B, Ben Fradj S, et al
    Automated IS6110-based fingerprinting of Mycobacterium tuberculosis: Reaching unprecedented discriminatory power and versatility.
    PLoS One. 2018;13:e0197913.
    PubMed     Text format     Abstract available


  64. LI L, Cheng Y, Emrich S, Schorey J, et al
    Activation of endothelial cells by extracellular vesicles derived from Mycobacterium tuberculosis infected macrophages or mice.
    PLoS One. 2018;13:e0198337.
    PubMed     Text format     Abstract available


  65. PAPP AC, Azad AK, Pietrzak M, Williams A, et al
    AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0198221.
    PubMed     Text format     Abstract available


  66. KIGOZI E, Kasule GW, Musisi K, Lukoye D, et al
    Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
    PLoS One. 2018;13:e0198091.
    PubMed     Text format     Abstract available


  67. KORTHALS ALTES H, Kloet S, Cobelens F, Bootsma M, et al
    Correction: Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling.
    PLoS One. 2018;13:e0198376.
    PubMed     Text format     Abstract available


  68. TADESSE S, Enqueselassie F, Hagos S
    Spatial and space-time clustering of tuberculosis in Gurage Zone, Southern Ethiopia.
    PLoS One. 2018;13:e0198353.
    PubMed     Text format     Abstract available


  69. MESFIN EA, Beyene D, Tesfaye A, Admasu A, et al
    Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    PLoS One. 2018;13:e0197737.
    PubMed     Text format     Abstract available


  70. ADESOKAN HK, Akinseye VO, Sulaimon MA
    Knowledge and practices about zoonotic tuberculosis prevention and associated determinants amongst livestock workers in Nigeria; 2015.
    PLoS One. 2018;13:e0198810.
    PubMed     Text format     Abstract available



  71. Correction: Association of body mass index with incident tuberculosis in Korea.
    PLoS One. 2018;13:e0199065.
    PubMed     Text format     Abstract available


  72. MCKINLEY TJ, Lipschutz-Powell D, Mitchell AP, Wood JLN, et al
    Risk factors and variations in detection of new bovine tuberculosis breakdowns via slaughterhouse surveillance in Great Britain.
    PLoS One. 2018;13:e0198760.
    PubMed     Text format     Abstract available


  73. BRAHAM CA, White PJ, Arinaminpathy N
    Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review.
    PLoS One. 2018;13:e0199413.
    PubMed     Text format     Abstract available


  74. YIHUNIE AKALU T, Muchie KF, Alemu Gelaye K
    Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.
    PLoS One. 2018;13:e0199320.
    PubMed     Text format     Abstract available


  75. KAWATSU L, Uchimura K, Ohkado A, Kato S, et al
    A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    PLoS One. 2018;13:e0198075.
    PubMed     Text format     Abstract available


  76. SSENGOOBA W, Nakayita G, Namaganda CC, Joloba ML, et al
    Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
    PLoS One. 2018;13:e0199638.
    PubMed     Text format     Abstract available


  77. MBU ET, Sauter F, Zoufaly A, Bronsvoort BMC, et al
    Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    PLoS One. 2018;13:e0199634.
    PubMed     Text format     Abstract available


  78. YU G, Shen Y, Zhong F, Ye B, et al
    Diagnostic accuracy of the loop-mediated isothermal amplification assay for extrapulmonary tuberculosis: A meta-analysis.
    PLoS One. 2018;13:e0199290.
    PubMed     Text format     Abstract available


  79. SHIBABAW A, Gelaw B, Wang SH, Tessema B, et al
    Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    PLoS One. 2018;13:e0198080.
    PubMed     Text format     Abstract available


  80. DESTA KT, Masango TE, Nkosi ZZ
    Performance of the National Tuberculosis Control Program in the post conflict Liberia.
    PLoS One. 2018;13:e0199474.
    PubMed     Text format     Abstract available


  81. NAFADE V, Nash M, Huddart S, Pande T, et al
    A bibliometric analysis of tuberculosis research, 2007-2016.
    PLoS One. 2018;13:e0199706.
    PubMed     Text format     Abstract available


  82. WAI PP, Shewade HD, Kyaw NTT, Thein S, et al
    Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.
    PLoS One. 2018;13:e0194087.
    PubMed     Text format     Abstract available


  83. MCDOWELL A, Raizada N, Khaparde SD, Rao R, et al
    "Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.
    PLoS One. 2018;13:e0193656.
    PubMed     Text format     Abstract available


  84. BOFFA J, Mayan M, Ndlovu S, Mhlaba T, et al
    The role of agency in the implementation of Isoniazid Preventive Therapy (IPT): Lessons from oMakoti in uMgungundlovu District, South Africa.
    PLoS One. 2018;13:e0193571.
    PubMed     Text format     Abstract available


  85. RAIZADA N, Khaparde SD, Swaminathan S, Sarin S, et al
    Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.
    PLoS One. 2018;13:e0193341.
    PubMed     Text format     Abstract available


  86. NDLOVU Z, Fajardo E, Mbofana E, Maparo T, et al
    Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    PLoS One. 2018;13:e0193577.
    PubMed     Text format     Abstract available


  87. CERQUEIRA-RODRIGUES B, Mendes A, Correia-Neves M, Nobrega C, et al
    Ag85-focused T-cell immune response controls Mycobacterium avium chronic infection.
    PLoS One. 2018;13:e0193596.
    PubMed     Text format     Abstract available


  88. JEONG DH, Kang J, Jung YJ, Yoo B, et al
    Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    PLoS One. 2018;13:e0198756.
    PubMed     Text format     Abstract available


  89. MARABA N, Hoffmann CJ, Chihota VN, Chang LW, et al
    Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study.
    PLoS One. 2018;13:e0199687.
    PubMed     Text format     Abstract available


  90. PAGE-SHIPP L, Lewis JJ, Velen K, Senoge S, et al
    Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
    PLoS One. 2018;13:e0192089.
    PubMed     Text format     Abstract available


  91. VELAYUTHAM B, Chadha VK, Singla N, Narang P, et al
    Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
    PLoS One. 2018;13:e0200150.
    PubMed     Text format     Abstract available


  92. WILLEMSE D, Weber B, Masino L, Warren RM, et al
    Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0200145.
    PubMed     Text format     Abstract available


  93. SILVA DAAD, Silva MVD, Barros CCO, Alexandre PBD, et al
    TNF-alpha blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines.
    PLoS One. 2018;13:e0194430.
    PubMed     Text format     Abstract available


  94. ZHANG R, Xi X, Wang C, Pan Y, et al
    Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0201025.
    PubMed     Text format     Abstract available


  95. BARUA M, Van Driel F, Jansen W
    Tuberculosis and the sexual and reproductive lives of women in Bangladesh.
    PLoS One. 2018;13:e0201134.
    PubMed     Text format     Abstract available


  96. MEYVISCH P, Kambili C, Andries K, Lounis N, et al
    Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.
    PLoS One. 2018;13:e0200539.
    PubMed     Text format     Abstract available


  97. PARRIOTT A, Malekinejad M, Miller AP, Horvath H, et al
    Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review.
    PLoS One. 2018;13:e0200485.
    PubMed     Text format     Abstract available


  98. ORLANDO S, Triulzi I, Ciccacci F, Palla I, et al
    Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    PLoS One. 2018;13:e0200523.
    PubMed     Text format     Abstract available


  99. PANDE T, Huddart S, Xavier W, Kulavalli S, et al
    Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis.
    PLoS One. 2018;13:e0200838.
    PubMed     Text format     Abstract available


  100. CHIANG TY, Fan SY, Jou R
    Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
    PLoS One. 2018;13:e0200755.
    PubMed     Text format     Abstract available


  101. MEEHAN SA, Sloot R, Draper HR, Naidoo P, et al
    Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa.
    PLoS One. 2018;13:e0195208.
    PubMed     Text format     Abstract available


  102. WALKER IF, Khanal S, Hicks JP, Lamichhane B, et al
    Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study.
    PLoS One. 2018;13:e0201163.
    PubMed     Text format     Abstract available


  103. GARCIA PJ, Hernandez-Cordova G, Pourjavaheri P, Gomez-Paredes HJ, et al
    Knowledge, attitudes and practices related to tuberculosis in pharmacy workers in a cross-sectional survey in El Agustino, Peru.
    PLoS One. 2018;13:e0196648.
    PubMed     Text format     Abstract available


  104. KOSTER K, Largen A, Foster JT, Drees KP, et al
    Whole genome SNP analysis suggests unique virulence factor differences of the Beijing and Manila families of Mycobacterium tuberculosis found in Hawaii.
    PLoS One. 2018;13:e0201146.
    PubMed     Text format     Abstract available


  105. CHIHOTA VN, Niehaus A, Streicher EM, Wang X, et al
    Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa.
    PLoS One. 2018;13:e0200632.
    PubMed     Text format     Abstract available


  106. DUTTA A, Pattanaik S, Choudhury R, Nanda P, et al
    Impact of involvement of non-formal health providers on TB case notification among migrant slum-dwelling populations in Odisha, India.
    PLoS One. 2018;13:e0196067.
    PubMed     Text format     Abstract available


  107. PATHMANATHAN I, Pasipamire M, Pals S, Dokubo EK, et al
    High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    PLoS One. 2018;13:e0196831.
    PubMed     Text format     Abstract available


  108. LOVEDAY M, Wallengren K, Reddy T, Besada D, et al
    MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
    PLoS One. 2018;13:e0196003.
    PubMed     Text format     Abstract available


  109. NGUYEN DT, Jenkins HE, Graviss EA
    Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.
    PLoS One. 2018;13:e0196022.
    PubMed     Text format     Abstract available


  110. MUTTAMBA W, Ssengooba W, Sekibira R, Kirenga B, et al
    Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    PLoS One. 2018;13:e0194741.
    PubMed     Text format     Abstract available


  111. JOSHI B, Lestari T, Graham SM, Baral SC, et al
    The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis.
    PLoS One. 2018;13:e0201731.
    PubMed     Text format     Abstract available


  112. PRIEDEMAN SKILES M, Curtis SL, Angeles G, Mullen S, et al
    Evaluating the impact of social support services on tuberculosis treatment default in Ukraine.
    PLoS One. 2018;13:e0199513.
    PubMed     Text format     Abstract available


  113. KO Y, Lee HY, Park YB, Hong SJ, et al
    Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis.
    PLoS One. 2018;13:e0201748.
    PubMed     Text format     Abstract available


  114. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Correction: Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0202292.
    PubMed     Text format     Abstract available


  115. MURADAS TC, Abbadi BL, Villela AD, Macchi FS, et al
    Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis.
    PLoS One. 2018;13:e0202568.
    PubMed     Text format     Abstract available


  116. BISOGNIN F, Lombardi G, Lombardo D, Re MC, et al
    Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples.
    PLoS One. 2018;13:e0201934.
    PubMed     Text format     Abstract available


  117. PEREA RAZO CA, Rodriguez Hernandez E, Ponce SIR, Milian Suazo F, et al
    Molecular epidemiology of cattle tuberculosis in Mexico through whole-genome sequencing and spoligotyping.
    PLoS One. 2018;13:e0201981.
    PubMed     Text format     Abstract available


  118. ANAND T, Kishore J, Isaakidis P, Gupte HA, et al
    Integrating screening for non-communicable diseases and their risk factors in routine tuberculosis care in Delhi, India: A mixed-methods study.
    PLoS One. 2018;13:e0202256.
    PubMed     Text format     Abstract available


  119. CHINGONZOH R, Manesen MR, Madlavu MJ, Sopiseka N, et al
    Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    PLoS One. 2018;13:e0202469.
    PubMed     Text format     Abstract available


  120. AVONG YK, Jatau B, Gurumnaan R, Danat N, et al
    Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    PLoS One. 2018;13:e0200810.
    PubMed     Text format     Abstract available


  121. SHARROCK A, Ruthe A, Andrews ESV, Arcus VA, et al
    VapC proteins from Mycobacterium tuberculosis share ribonuclease sequence specificity but differ in regulation and toxicity.
    PLoS One. 2018;13:e0203412.
    PubMed     Text format     Abstract available


  122. HIZA H, Fenner L, Hella J, Kuchaka D, et al
    Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0202525.
    PubMed     Text format     Abstract available


  123. SANTOS AP, Correa RDS, Ribeiro-Alves M, Soares da Silva ACO, et al
    Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-gamma, IP-10 and adenosine deaminase.
    PLoS One. 2018;13:e0202481.
    PubMed     Text format     Abstract available


  124. KAWATSU L, Uchimura K, Ohkado A
    A situational analysis of latent tuberculosis infection among incarcerated population in Japan.
    PLoS One. 2018;13:e0203815.
    PubMed     Text format     Abstract available


  125. CHANG CH, Hu CC, Chang Y, Hsieh PH, et al
    Two-stage revision arthroplasty for Mycobacterium Tuberculosis periprosthetic joint infection: An outcome analysis.
    PLoS One. 2018;13:e0203585.
    PubMed     Text format     Abstract available


  126. ALIYU G, El-Kamary SS, Abimiku A, Blattner W, et al
    Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa.
    PLoS One. 2018;13:e0191387.
    PubMed     Text format     Abstract available


  127. JORSTAD MD, Amus J, Marijani M, Sviland L, et al
    Diagnostic delay in extrapulmonary tuberculosis and impact on patient morbidity: A study from Zanzibar.
    PLoS One. 2018;13:e0203593.
    PubMed     Text format     Abstract available


  128. TEMESSZENTANDRASI-AMBRUS C, Toth S, Verma R, Banhegyi P, et al
    Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters.
    PLoS One. 2018;13:e0202749.
    PubMed     Text format     Abstract available


  129. GUEDES L, Jaeger LH, Liryo A, Rodrigues-Carvalho C, et al
    Tuberculosis in post-contact Native Americans of Brazil: Paleopathological and paleogenetic evidence from the Tenetehara-Guajajara.
    PLoS One. 2018;13:e0202394.
    PubMed     Text format     Abstract available


  130. MOHR E, Snyman L, Mbakaz Z, Caldwell J, et al
    "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.
    PLoS One. 2018;13:e0203888.
    PubMed     Text format     Abstract available


  131. TOGUN TO, MacLean E, Kampmann B, Pai M, et al
    Biomarkers for diagnosis of childhood tuberculosis: A systematic review.
    PLoS One. 2018;13:e0204029.
    PubMed     Text format     Abstract available


  132. RAHMAN SMM, Maliha UT, Ahmed S, Kabir S, et al
    Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
    PLoS One. 2018;13:e0203063.
    PubMed     Text format     Abstract available


  133. HUAMAN MA, Henson D, Rondan PL, Ticona E, et al
    Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.
    PLoS One. 2018;13:e0202191.
    PubMed     Text format     Abstract available


  134. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Text format     Abstract available


  135. MADEIRA DE OLIVEIRA S, Altmayer S, Zanon M, Alves Sidney-Filho L, et al
    Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America.
    PLoS One. 2018;13:e0202593.
    PubMed     Text format     Abstract available



  136. Retraction: Survival Analysis of Adult Tuberculosis Disease.
    PLoS One. 2018;13:e0204676.
    PubMed     Text format    


  137. PARK Y, Kim SY, Kim JW, Park MS, et al
    Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis.
    PLoS One. 2018;13:e0204035.
    PubMed     Text format     Abstract available


  138. YAHYAOUI AZAMI H, Ducrotoy MJ, Bouslikhane M, Hattendorf J, et al
    The prevalence of brucellosis and bovine tuberculosis in ruminants in Sidi Kacem Province, Morocco.
    PLoS One. 2018;13:e0203360.
    PubMed     Text format     Abstract available


  139. MEKONNEN A, Merker M, Collins JM, Addise D, et al
    Molecular epidemiology and drug resistance patterns of Mycobacterium tuberculosis complex isolates from university students and the local community in Eastern Ethiopia.
    PLoS One. 2018;13:e0198054.
    PubMed     Text format     Abstract available


  140. MONTGOMERY SA, Young EF, Durham PG, Zulauf KE, et al
    Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
    PLoS One. 2018;13:e0204495.
    PubMed     Text format     Abstract available


  141. BARON S, Peleg Y, Grunwald J, Morgenstern D, et al
    Expression of a recombinant, 4'-Phosphopantetheinylated, active M. tuberculosis fatty acid synthase I in E. coli.
    PLoS One. 2018;13:e0204457.
    PubMed     Text format     Abstract available


  142. AGGERBECK H, Ruhwald M, Hoff ST, Borregaard B, et al
    C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial.
    PLoS One. 2018;13:e0204554.
    PubMed     Text format     Abstract available


  143. ARYA S, Kumar SK, Nath A, Kapoor P, et al
    Synergy between tuberculin skin test and proliferative T cell responses to PPD or cell-membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting.
    PLoS One. 2018;13:e0204429.
    PubMed     Text format     Abstract available


  144. MADAN C, Chopra KK, Satyanarayana S, Surie D, et al
    Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.
    PLoS One. 2018;13:e0204982.
    PubMed     Text format     Abstract available


  145. KIMUDA SG, Biraro IA, Bagaya BS, Raynes JG, et al
    Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance.
    PLoS One. 2018;13:e0205102.
    PubMed     Text format     Abstract available


  146. COLLINS JM, Walker DI, Jones DP, Tukvadze N, et al
    High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
    PLoS One. 2018;13:e0205398.
    PubMed     Text format     Abstract available


  147. VAN DE BERG S, Jansen-Aaldring N, de Vries G, van den Hof S, et al
    Patient support for tuberculosis patients in low-incidence countries: A systematic review.
    PLoS One. 2018;13:e0205433.
    PubMed     Text format     Abstract available


  148. WU K, Koo J, Jiang X, Chen R, et al
    Correction: Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R.
    PLoS One. 2018;13:e0205424.
    PubMed     Text format     Abstract available


  149. VERDECCHIA M, Keus K, Blankley S, Vambe D, et al
    Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011-2013.
    PLoS One. 2018;13:e0205601.
    PubMed     Text format     Abstract available


  150. BONNETT SA, Dennison D, Files M, Bajpai A, et al
    A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0198059.
    PubMed     Text format     Abstract available


  151. KIELMANN K, Vidal N, Riekstina V, Krutikov M, et al
    "Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.
    PLoS One. 2018;13:e0203937.
    PubMed     Text format     Abstract available


  152. ROBA AA, Dasa TT, Weldegebreal F, Asfaw A, et al
    Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health Related Quality of Life in Eastern Ethiopia.
    PLoS One. 2018;13:e0204697.
    PubMed     Text format     Abstract available


    January 2017
  153. TORNACK J, Reece ST, Bauer WM, Vogelzang A, et al
    Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0169119.
    PubMed     Text format     Abstract available


  154. LAI HH, Lai YJ, Yen YF
    Association of Body Mass Index with Timing of Death during Tuberculosis Treatment.
    PLoS One. 2017;12:e0170104.
    PubMed     Text format     Abstract available


  155. SARIKO M, Anderson C, Mujaga BS, Gratz J, et al
    Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.
    PLoS One. 2017;12:e0169118.
    PubMed     Text format     Abstract available


  156. PANDEY P, Pant ND, Rijal KR, Shrestha B, et al
    Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis.
    PLoS One. 2017;12:e0169798.
    PubMed     Text format     Abstract available


  157. XIA H, Zheng Y, Zhao B, van den Hof S, et al
    Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
    PLoS One. 2017;12:e0169413.
    PubMed     Text format     Abstract available


  158. SERRANO M, Elguezabal N, Sevilla IA, Geijo MV, et al
    Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.
    PLoS One. 2017;12:e0169735.
    PubMed     Text format     Abstract available


  159. MWANSA-KAMBAFWILE J, Maitshotlo B, Black A
    Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
    PLoS One. 2017;12:e0168659.
    PubMed     Text format     Abstract available


  160. SHARMA SK, Vashishtha R, Chauhan LS, Sreenivas V, et al
    Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting.
    PLoS One. 2017;12:e0169539.
    PubMed     Text format     Abstract available


  161. KHARE G, Nangpal P, Tyagi AK
    Differential Roles of Iron Storage Proteins in Maintaining the Iron Homeostasis in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0169545.
    PubMed     Text format     Abstract available


  162. ANDRE E, Lufungulo Bahati Y, Mulume Musafiri E, Bahati Rusumba O, et al
    Prediction of Under-Detection of Paediatric Tuberculosis in the Democratic Republic of Congo: Experience of Six Years in the South-Kivu Province.
    PLoS One. 2017;12:e0169014.
    PubMed     Text format     Abstract available


  163. KHANAL S, Elsey H, King R, Baral SC, et al
    Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
    PLoS One. 2017;12:e0167559.
    PubMed     Text format     Abstract available


  164. LOPEZ-VARELA E, L Garcia-Basteiro A, Augusto OJ, Fraile O, et al
    High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.
    PLoS One. 2017;12:e0169757.
    PubMed     Text format     Abstract available


  165. CHEN MY, Lo YC, Chen WC, Wang KF, et al
    Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan.
    PLoS One. 2017;12:e0170980.
    PubMed     Text format     Abstract available


  166. FU Y, Xu X, Xue J, Duan W, et al
    Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis.
    PLoS One. 2017;12:e0170712.
    PubMed     Text format     Abstract available


  167. GORMLEY E, Ni Bhuachalla D, O'Keeffe J, Murphy D, et al
    Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis.
    PLoS One. 2017;12:e0168851.
    PubMed     Text format     Abstract available


  168. SUN Y, Harley D, Vally H, Sleigh A, et al
    Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China.
    PLoS One. 2017;12:e0168865.
    PubMed     Text format     Abstract available


  169. HUHNS M, Erbersdobler A, Obliers A, Ropenack P, et al
    Identification of HPV Types and Mycobacterium Tuberculosis Complex in Historical Long-Term Preserved Formalin Fixed Tissues in Different Human Organs.
    PLoS One. 2017;12:e0170353.
    PubMed     Text format     Abstract available


  170. XU Z, Xiao T, Li Y, Yang K, et al
    Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China.
    PLoS One. 2017;12:e0170718.
    PubMed     Text format     Abstract available


  171. MORISHITA F, Garfin AM, Lew W, Oh KH, et al
    Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines.
    PLoS One. 2017;12:e0171310.
    PubMed     Text format     Abstract available


  172. ZHANG Z, Ordonez AA, Smith-Jones P, Wang H, et al
    The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography.
    PLoS One. 2017;12:e0170871.
    PubMed     Text format     Abstract available


  173. EBERS A, Stroup S, Mpagama S, Kisonga R, et al
    Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania.
    PLoS One. 2017;12:e0170663.
    PubMed     Text format     Abstract available


  174. MACHOVA I, Hubalek M, Lepsik M, Bednarova L, et al
    The Role of Cysteine Residues in Catalysis of Phosphoenolpyruvate Carboxykinase from Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0170373.
    PubMed     Text format     Abstract available


  175. ALENE KA, Viney K, McBryde ES, Clements AC, et al
    Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia.
    PLoS One. 2017;12:e0171800.
    PubMed     Text format     Abstract available


  176. REYNAUD Y, Zheng C, Wu G, Sun Q, et al
    Bayesian population structure analysis reveals presence of phylogeographically specific sublineages within previously ill-defined T group of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0171584.
    PubMed     Text format     Abstract available


  177. HUNDIE GB, Woldemeskel D, Gessesse A
    Correction: Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0171964.
    PubMed     Text format     Abstract available


  178. LA MANNA MP, Orlando V, Dieli F, Di Carlo P, et al
    Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages.
    PLoS One. 2017;12:e0171358.
    PubMed     Text format     Abstract available


  179. NAIDOO P, Dunbar R, Caldwell J, Lombard C, et al
    Has universal screening with Xpert(R) MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?
    PLoS One. 2017;12:e0172143.
    PubMed     Text format     Abstract available


  180. VLUGGEN C, Soetaert K, Groenen G, Wanlin M, et al
    Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010-2013.
    PLoS One. 2017;12:e0172554.
    PubMed     Text format     Abstract available


  181. GHIELMETTI G, Scherrer S, Friedel U, Frei D, et al
    Epidemiological tracing of bovine tuberculosis in Switzerland, multilocus variable number of tandem repeat analysis of Mycobacterium bovis and Mycobacterium caprae.
    PLoS One. 2017;12:e0172474.
    PubMed     Text format     Abstract available


  182. MARIN D, Marin N, Del Corral H, Lopez L, et al
    PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study.
    PLoS One. 2017;12:e0171930.
    PubMed     Text format     Abstract available


  183. NABETA P, Havumaki J, Ha DT, Caceres T, et al
    Feasibility of the TBDx automated digital microscopy system for the diagnosis of pulmonary tuberculosis.
    PLoS One. 2017;12:e0173092.
    PubMed     Text format     Abstract available


  184. HERMOSILLA S, You P, Aifah A, Abildayev T, et al
    Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan.
    PLoS One. 2017;12:e0172942.
    PubMed     Text format     Abstract available


  185. JIANG TT, Shi LY, Wei LL, Li X, et al
    Serum amyloid A, protein Z, and C4b-binding protein beta chain as new potential biomarkers for pulmonary tuberculosis.
    PLoS One. 2017;12:e0173304.
    PubMed     Text format     Abstract available


  186. LEE HJ, Lee DG, Choi SM, Park SH, et al
    The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.
    PLoS One. 2017;12:e0173250.
    PubMed     Text format     Abstract available


  187. KENDALL EA, Azman AS, Cobelens FG, Dowdy DW, et al
    MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0172748.
    PubMed     Text format     Abstract available


  188. SHARPE SA, White AD, Sibley L, Gleeson F, et al
    An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0171906.
    PubMed     Text format     Abstract available


  189. OJO OB, Lougue S, Woldegerima WA
    Bayesian generalized linear mixed modeling of Tuberculosis using informative priors.
    PLoS One. 2017;12:e0172580.
    PubMed     Text format     Abstract available


  190. CLAASSENS MM, van Schalkwyk C, Floyd S, Ayles H, et al
    Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.
    PLoS One. 2017;12:e0172881.
    PubMed     Text format     Abstract available


  191. ALMEIDA FM, Ventura TL, Amaral EP, Ribeiro SC, et al
    Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    PLoS One. 2017;12:e0173715.
    PubMed     Text format     Abstract available


  192. SHARMA S, Ryndak MB, Aggarwal AN, Yadav R, et al
    Transcriptome analysis of mycobacteria in sputum samples of pulmonary tuberculosis patients.
    PLoS One. 2017;12:e0173508.
    PubMed     Text format     Abstract available


  193. PATHMANATHAN I, Dokubo EK, Shiraishi RW, Agolory SG, et al
    Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
    PLoS One. 2017;12:e0173309.
    PubMed     Text format     Abstract available


  194. DROZNIN M, Johnson A, Johnson AM
    Multidrug resistant tuberculosis in prisons located in former Soviet countries: A systematic review.
    PLoS One. 2017;12:e0174373.
    PubMed     Text format     Abstract available


  195. KARAT AS, Tlali M, Fielding KL, Charalambous S, et al
    Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data.
    PLoS One. 2017;12:e0174097.
    PubMed     Text format     Abstract available


  196. ZHOU Y, van den Hof S, Wang S, Pang Y, et al
    Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey.
    PLoS One. 2017;12:e0174197.
    PubMed     Text format     Abstract available


  197. FAN L, Shen H, Huang H, Yang R, et al
    Impairment of Wnt/beta-catenin signaling in blood cells of patients with severe cavitary pulmonary tuberculosis.
    PLoS One. 2017;12:e0172549.
    PubMed     Text format     Abstract available


  198. MOORES A, Riesco AB, Schwenk S, Arnvig KB, et al
    Expression, maturation and turnover of DrrS, an unusually stable, DosR regulated small RNA in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0174079.
    PubMed     Text format     Abstract available


  199. VIDYARTHI A, Khan N, Agnihotri T, Siddiqui KF, et al
    Antibody response against PhoP efficiently discriminates among healthy individuals, tuberculosis patients and their contacts.
    PLoS One. 2017;12:e0173769.
    PubMed     Text format     Abstract available


  200. ADANE K, Spigt M, Johanna L, Noortje D, et al
    Tuberculosis knowledge, attitudes, and practices among northern Ethiopian prisoners: Implications for TB control efforts.
    PLoS One. 2017;12:e0174692.
    PubMed     Text format     Abstract available


  201. CUI Z, Lin M, Nie S, Lan R, et al
    Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.
    PLoS One. 2017;12:e0173976.
    PubMed     Text format     Abstract available


  202. HONG EP, Go MJ, Kim HL, Park JW, et al
    Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population.
    PLoS One. 2017;12:e0174642.
    PubMed     Text format     Abstract available


  203. KIM C, Park SH, Oh SY, Kim SS, et al
    Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities.
    PLoS One. 2017;12:e0174240.
    PubMed     Text format     Abstract available


  204. HAVUMAKI J, Hillemann D, Ismail N, Omar SV, et al
    Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study.
    PLoS One. 2017;12:e0173804.
    PubMed     Text format     Abstract available


  205. LOPEZ-VARELA E, Garcia-Basteiro AL, Augusto OJ, Fraile O, et al
    Correction: High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.
    PLoS One. 2017;12:e0175613.
    PubMed     Text format     Abstract available


  206. MIRANDA P, Gil-Santana L, Oliveira MG, Mesquita ED, et al
    Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
    PLoS One. 2017;12:e0175278.
    PubMed     Text format     Abstract available


  207. ZHANG H, Xin H, Li X, Li H, et al
    A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China.
    PLoS One. 2017;12:e0175183.
    PubMed     Text format     Abstract available


  208. ALMEIDA FM, Ventura TL, Amaral EP, Ribeiro SC, et al
    Correction: Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    PLoS One. 2017;12:e0175652.
    PubMed     Text format     Abstract available


  209. KE CC, Lin CS, Yeh CC, Chung CL, et al
    Correction: Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study.
    PLoS One. 2017;12:e0175603.
    PubMed     Text format     Abstract available


  210. UREN C, Henn BM, Franke A, Wittig M, et al
    A post-GWAS analysis of predicted regulatory variants and tuberculosis susceptibility.
    PLoS One. 2017;12:e0174738.
    PubMed     Text format     Abstract available


  211. KHALIQ A, Ravindran R, Hussainy SF, Krishnan VV, et al
    Field evaluation of a blood based test for active tuberculosis in endemic settings.
    PLoS One. 2017;12:e0173359.
    PubMed     Text format     Abstract available


  212. GAO Y, Ou Y, Deng Q, He B, et al
    Comparison between titanium mesh and autogenous iliac bone graft to restore vertebral height through posterior approach for the treatment of thoracic and lumbar spinal tuberculosis.
    PLoS One. 2017;12:e0175567.
    PubMed     Text format     Abstract available


  213. BALCELLS ME, Garcia P, Tiznado C, Villarroel L, et al
    Association of vitamin D deficiency, season of the year, and latent tuberculosis infection among household contacts.
    PLoS One. 2017;12:e0175400.
    PubMed     Text format     Abstract available


  214. PARDESHI P, Rao KK, Balaji PV
    Rv3634c from Mycobacterium tuberculosis H37Rv encodes an enzyme with UDP-Gal/Glc and UDP-GalNAc 4-epimerase activities.
    PLoS One. 2017;12:e0175193.
    PubMed     Text format     Abstract available


  215. SHAH J, Weltman H, Narciso P, Murphy C, et al
    Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures.
    PLoS One. 2017;12:e0174989.
    PubMed     Text format     Abstract available


  216. WAN X, Koster K, Qian L, Desmond E, et al
    Genomic analyses of the ancestral Manila family of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0175330.
    PubMed     Text format     Abstract available


  217. LEE SW, Liu CW, Hu JY, Chiang LM, et al
    Suppressors of cytokine signaling in tuberculosis.
    PLoS One. 2017;12:e0176377.
    PubMed     Text format     Abstract available


  218. LOMBARDI G, Di Gregori V, Girometti N, Tadolini M, et al
    Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF.
    PLoS One. 2017;12:e0176186.
    PubMed     Text format     Abstract available


  219. WORKNEH MH, Bjune GA, Yimer SA
    Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review.
    PLoS One. 2017;12:e0175925.
    PubMed     Text format     Abstract available


  220. DEJENE SW, Heitkonig IMA, Prins HHT, Lemma FA, et al
    Correction: Risk Factors for Bovine Tuberculosis (bTB) in Cattle in Ethiopia.
    PLoS One. 2017;12:e0176654.
    PubMed     Text format     Abstract available


  221. KASTIEN-HILKA T, Rosenkranz B, Sinanovic E, Bennett B, et al
    Health-related quality of life in South African patients with pulmonary tuberculosis.
    PLoS One. 2017;12:e0174605.
    PubMed     Text format     Abstract available


  222. NHAVOTO JA, Gronlund A, Klein GO
    Mobile health treatment support intervention for HIV and tuberculosis in Mozambique: Perspectives of patients and healthcare workers.
    PLoS One. 2017;12:e0176051.
    PubMed     Text format     Abstract available


  223. PELISSARI DM, Diaz-Quijano FA
    Household crowding as a potential mediator of socioeconomic determinants of tuberculosis incidence in Brazil.
    PLoS One. 2017;12:e0176116.
    PubMed     Text format     Abstract available


  224. SESHADRI C, Sedaghat N, Campo M, Peterson G, et al
    Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection.
    PLoS One. 2017;12:e0175844.
    PubMed     Text format     Abstract available


  225. KUMAR NP, Banurekha VV, Nair D, Babu S, et al
    Diminished plasma levels of common gamma-chain cytokines in pulmonary tuberculosis and reversal following treatment.
    PLoS One. 2017;12:e0176495.
    PubMed     Text format     Abstract available


  226. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Text format     Abstract available


  227. PANZER S, Wittig H, Zesch S, Rosendahl W, et al
    Evidence of neurofibromatosis type 1 in a multi-morbid Inca child mummy: A paleoradiological investigation using computed tomography.
    PLoS One. 2017;12:e0175000.
    PubMed     Text format     Abstract available


  228. GADOEV J, Asadov D, Harries AD, Parpieva N, et al
    Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan.
    PLoS One. 2017;12:e0176473.
    PubMed     Text format     Abstract available


  229. FERRIAN S, Manca C, Lubbe S, Conradie F, et al
    A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.
    PLoS One. 2017;12:e0176660.
    PubMed     Text format     Abstract available


  230. VON REYN CF, Lahey T, Arbeit RD, Landry B, et al
    Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    PLoS One. 2017;12:e0175215.
    PubMed     Text format     Abstract available


  231. LEMPP JM, Zajdowicz MJ, Hankinson AL, Toney SR, et al
    Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.
    PLoS One. 2017;12:e0177752.
    PubMed     Text format     Abstract available


  232. OPERARIO DJ, Koeppel AF, Turner SD, Bao Y, et al
    Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0176522.
    PubMed     Text format     Abstract available


  233. CHOI SR, Britigan BE, Moran DM, Narayanasamy P, et al
    Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.
    PLoS One. 2017;12:e0177987.
    PubMed     Text format     Abstract available


  234. MOHR E, Daniels J, Beko B, Isaakidis P, et al
    DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
    PLoS One. 2017;12:e0178054.
    PubMed     Text format     Abstract available


  235. ABAYE GE, Abebe T, Worku A, Tolessa D, et al
    Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosis.
    PLoS One. 2017;12:e0177529.
    PubMed     Text format     Abstract available


  236. ZHANG L, Cheng X, Bian S, Song Y, et al
    Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
    PLoS One. 2017;12:e0177850.
    PubMed     Text format     Abstract available


  237. XIAO Y, Yu S, Xue Q, Lang S, et al
    A scoring system to effectively evaluate central nervous system tuberculosis in patients with military tuberculosis.
    PLoS One. 2017;12:e0176651.
    PubMed     Text format     Abstract available


  238. MICHELSEN SW, Soborg B, Diaz LJ, Hoff ST, et al
    The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.
    PLoS One. 2017;12:e0177906.
    PubMed     Text format     Abstract available


  239. LIM CH, Chen HH, Chen YH, Chen DY, et al
    The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.
    PLoS One. 2017;12:e0178035.
    PubMed     Text format     Abstract available


  240. QADER G, Hamim A, Sayedi M, Rashidi M, et al
    Addressing tuberculosis control in fragile states: Urban DOTS experience in Kabul, Afghanistan, 2009-2015.
    PLoS One. 2017;12:e0178053.
    PubMed     Text format     Abstract available


  241. KUMAR NP, Moideen K, Dolla C, Kumaran P, et al
    Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection.
    PLoS One. 2017;12:e0178000.
    PubMed     Text format     Abstract available


  242. NENASHEVA T, Nikolaev A, Diykanov D, Sukhanova A, et al
    The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice.
    PLoS One. 2017;12:e0178983.
    PubMed     Text format     Abstract available


  243. LI D, He W, Chen B, Lv P, et al
    Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings.
    PLoS One. 2017;12:e0176354.
    PubMed     Text format     Abstract available


  244. USTERO PA, Kay AW, Ngo K, Golin R, et al
    School and household tuberculosis contact investigations in Swaziland: Active TB case finding in a high HIV/TB burden setting.
    PLoS One. 2017;12:e0178873.
    PubMed     Text format     Abstract available


  245. KHAN MS, Hutchison C, Coker RJ
    Risk factors that may be driving the emergence of drug resistance in tuberculosis patients treated in Yangon, Myanmar.
    PLoS One. 2017;12:e0177999.
    PubMed     Text format     Abstract available


  246. PUCKEN VB, Knubben-Schweizer G, Dopfer D, Groll A, et al
    Evaluating diagnostic tests for bovine tuberculosis in the southern part of Germany: A latent class analysis.
    PLoS One. 2017;12:e0179847.
    PubMed     Text format     Abstract available


  247. WANG L, Li R, Xu C, Zhang H, et al
    The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership.
    PLoS One. 2017;12:e0177536.
    PubMed     Text format     Abstract available


  248. HUANG LK, Wang HH, Lai YC, Chang SC, et al
    The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients.
    PLoS One. 2017;12:e0179750.
    PubMed     Text format     Abstract available


  249. JIAO W, Blackmore NJ, Nazmi AR, Parker EJ, et al
    Quaternary structure is an essential component that contributes to the sophisticated allosteric regulation mechanism in a key enzyme from Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0180052.
    PubMed     Text format     Abstract available


  250. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Text format     Abstract available


  251. ABRAHAM PR, Pathak N, Pradhan G, Sumanlatha G, et al
    The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients.
    PLoS One. 2017;12:e0179965.
    PubMed     Text format     Abstract available


  252. DUNCAN C, Jamieson FB, Troudt J, Izzo L, et al
    Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion.
    PLoS One. 2017;12:e0179996.
    PubMed     Text format     Abstract available


  253. MEYER AJ, Atuheire C, Worodria W, Kizito S, et al
    Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.
    PLoS One. 2017;12:e0180572.
    PubMed     Text format     Abstract available


  254. OPERARIO DJ, Koeppel AF, Turner SD, Bao Y, et al
    Correction: Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0181284.
    PubMed     Text format     Abstract available


  255. BALSEIRO A, Altuzarra R, Vidal E, Moll X, et al
    Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.
    PLoS One. 2017;12:e0180546.
    PubMed     Text format     Abstract available


  256. WUBULI A, Li Y, Xue F, Yao X, et al
    Seasonality of active tuberculosis notification from 2005 to 2014 in Xinjiang, China.
    PLoS One. 2017;12:e0180226.
    PubMed     Text format     Abstract available


  257. LI S, Liu B, Peng M, Chen M, et al
    Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180725.
    PubMed     Text format     Abstract available


  258. IDH J, Andersson B, Lerm M, Raffetseder J, et al
    Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages.
    PLoS One. 2017;12:e0181221.
    PubMed     Text format     Abstract available


  259. ONYEDUM CC, Alobu I, Ukwaja KN
    Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180996.
    PubMed     Text format     Abstract available


  260. MAGEE MJ, Sun YV, Brust JCM, Shah NS, et al
    Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.
    PLoS One. 2017;12:e0180916.
    PubMed     Text format     Abstract available


  261. SIMA BT, Belachew T, Abebe F
    Knowledge, attitude and perceived stigma towards tuberculosis among pastoralists; Do they differ from sedentary communities? A comparative cross-sectional study.
    PLoS One. 2017;12:e0181032.
    PubMed     Text format     Abstract available


  262. KO Y, Song J, Lee SY, Moon JW, et al
    Does repeated pleural culture increase the diagnostic yield of Mycobacterium tuberculosis from tuberculous pleural effusion in HIV-negative individuals?
    PLoS One. 2017;12:e0181798.
    PubMed     Text format     Abstract available


  263. JEON AB, Obregon-Henao A, Ackart DF, Podell BK, et al
    2-aminoimidazoles potentiate ss-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ss-lactamase secretion and increasing cell envelope permeability.
    PLoS One. 2017;12:e0180925.
    PubMed     Text format     Abstract available


  264. EVANS D, Schnippel K, Govathson C, Sineke T, et al
    Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2017;12:e0181238.
    PubMed     Text format     Abstract available


  265. MYLLYMAKI H, Niskanen M, Oksanen KE, Sherwood E, et al
    Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio).
    PLoS One. 2017;12:e0181942.
    PubMed     Text format     Abstract available


  266. HANIFA Y, Fielding KL, Chihota VN, Adonis L, et al
    A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa.
    PLoS One. 2017;12:e0181519.
    PubMed     Text format     Abstract available



  267. Correction: A scoring system to effectively evaluate central nervous system tuberculosis in patients with miliary tuberculosis.
    PLoS One. 2017;12:e0182713.
    PubMed     Text format     Abstract available


  268. SHETE PB, Ravindran R, Chang E, Worodria W, et al
    Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda.
    PLoS One. 2017;12:e0180122.
    PubMed     Text format     Abstract available


  269. SZKWARKO D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, et al
    Child contact management in high tuberculosis burden countries: A mixed-methods systematic review.
    PLoS One. 2017;12:e0182185.
    PubMed     Text format     Abstract available


  270. GETAHUN B, Nkosi ZZ
    Is directly observed tuberculosis treatment strategy patient-centered? A mixed method study in Addis Ababa, Ethiopia.
    PLoS One. 2017;12:e0181205.
    PubMed     Text format     Abstract available


  271. SERI B, Koffi A, Danel C, Ouassa T, et al
    Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Cote d'Ivoire.
    PLoS One. 2017;12:e0181995.
    PubMed     Text format     Abstract available


  272. RIVIERE J, Le Strat Y, Hendrikx P, Dufour B, et al
    Cost-effectiveness evaluation of bovine tuberculosis surveillance in wildlife in France (Sylvatub system) using scenario trees.
    PLoS One. 2017;12:e0183126.
    PubMed     Text format     Abstract available


  273. FONSECA BPFE, Silva MVPD, Araujo KM, Sampaio RB, et al
    Network analysis for science and technology management: Evidence from tuberculosis research in Fiocruz, Brazil.
    PLoS One. 2017;12:e0181870.
    PubMed     Text format     Abstract available


  274. MALEKINEJAD M, Parriott A, Viitanen AP, Horvath H, et al
    Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review.
    PLoS One. 2017;12:e0180707.
    PubMed     Text format     Abstract available


  275. FARLEY JE, Ndjeka N, Kelly AM, Whitehouse E, et al
    Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa.
    PLoS One. 2017;12:e0182780.
    PubMed     Text format     Abstract available


  276. MANDALAKAS AM, Ngo K, Alonso Ustero P, Golin R, et al
    BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing.
    PLoS One. 2017;12:e0169769.
    PubMed     Text format     Abstract available


  277. LIU H, Zheng R, Wang P, Yang H, et al
    IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation.
    PLoS One. 2017;12:e0169922.
    PubMed     Text format     Abstract available


  278. HAMEED S, Moganeradj K, Mahmood N, McHugh TD, et al
    Sequence analysis of the rifampicin resistance determining region (RRDR) of rpoB gene in multidrug resistance confirmed and newly diagnosed tuberculosis patients of Punjab, Pakistan.
    PLoS One. 2017;12:e0183363.
    PubMed     Text format     Abstract available


  279. TRIPP L, Sawchuk LA
    Insights into secular trends of respiratory tuberculosis: The 20th century Maltese experience.
    PLoS One. 2017;12:e0183296.
    PubMed     Text format     Abstract available


  280. ADAMU AL, Aliyu MH, Galadanci NA, Musa BM, et al
    Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria.
    PLoS One. 2017;12:e0183270.
    PubMed     Text format     Abstract available


  281. SUBBARAMAN R, Thomas BE, Sellappan S, Suresh C, et al
    Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?
    PLoS One. 2017;12:e0183240.
    PubMed     Text format     Abstract available


  282. CASTRO-GARZA J, Garcia-Jacobo P, Rivera-Morales LG, Quinn FD, et al
    Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0181714.
    PubMed     Text format     Abstract available


  283. JONES A, Pitts M, Al Dulayymi JR, Gibbons J, et al
    New synthetic lipid antigens for rapid serological diagnosis of tuberculosis.
    PLoS One. 2017;12:e0181414.
    PubMed     Text format     Abstract available


  284. REYES-ALDASORO CC
    The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"?
    PLoS One. 2017;12:e0173671.
    PubMed     Text format     Abstract available


  285. KIMARO GD, Mfinanga S, Simms V, Kivuyo S, et al
    The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    PLoS One. 2017;12:e0171917.
    PubMed     Text format     Abstract available


  286. HUERGA H, Ferlazzo G, Bevilacqua P, Kirubi B, et al
    Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    PLoS One. 2017;12:e0170976.
    PubMed     Text format     Abstract available


  287. CHIACCHIO T, Delogu G, Vanini V, Cuzzi G, et al
    Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    PLoS One. 2017;12:e0183846.
    PubMed     Text format     Abstract available


  288. HOCHBERG NS, Sarkar S, Horsburgh CR Jr, Knudsen S, et al
    Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention.
    PLoS One. 2017;12:e0183195.
    PubMed     Text format     Abstract available


  289. SINGH BK, Sharma SK, Sharma R, Sreenivas V, et al
    Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis.
    PLoS One. 2017;12:e0182988.
    PubMed     Text format     Abstract available


  290. ESPINOSA-CUETO P, Magallanes-Puebla A, Castellanos C, Mancilla R, et al
    Dendritic cells that phagocytose apoptotic macrophages loaded with mycobacterial antigens activate CD8 T cells via cross-presentation.
    PLoS One. 2017;12:e0182126.
    PubMed     Text format     Abstract available


  291. HAIMOVICH JS, Venkatesh AK, Shojaee A, Coppi A, et al
    Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.
    PLoS One. 2017;12:e0172049.
    PubMed     Text format     Abstract available


  292. HATTHAKAROON C, Pharkjaksu S, Chongtrakool P, Suwannakarn K, et al
    Molecular epidemiology of cryptococcal genotype VNIc/ST5 in Siriraj Hospital, Thailand.
    PLoS One. 2017;12:e0173744.
    PubMed     Text format     Abstract available


  293. BRUFFAERTS N, Vluggen C, Roupie V, Duytschaever L, et al
    Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp. hominissuis in an experimental mouse infection.
    PLoS One. 2017;12:e0171895.
    PubMed     Text format     Abstract available


  294. BAGUMA R, Penn-Nicholson A, Smit E, Erasmus M, et al
    Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
    PLoS One. 2017;12:e0184563.
    PubMed     Text format     Abstract available


  295. MARANGU D, Mwaniki H, Nduku S, Maleche-Obimbo E, et al
    Stakeholder perspectives for optimization of tuberculosis contact investigation in a high-burden setting.
    PLoS One. 2017;12:e0183749.
    PubMed     Text format     Abstract available


  296. PHILLIPS BL, Gautam US, Bucsan AN, Foreman TW, et al
    LAG-3 potentiates the survival of Mycobacterium tuberculosis in host phagocytes by modulating mitochondrial signaling in an in-vitro granuloma model.
    PLoS One. 2017;12:e0180413.
    PubMed     Text format     Abstract available


  297. KHAPARDE S, Raizada N, Nair SA, Denkinger C, et al
    Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.
    PLoS One. 2017;12:e0184270.
    PubMed     Text format     Abstract available


  298. TKACHUK AP, Gushchin VA, Potapov VD, Demidenko AV, et al
    Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    PLoS One. 2017;12:e0176784.
    PubMed     Text format     Abstract available


  299. GETAHUN B, Nkosi ZZ
    Satisfaction of patients with directly observed treatment strategy in Addis Ababa, Ethiopia: A mixed-methods study.
    PLoS One. 2017;12:e0171209.
    PubMed     Text format     Abstract available


  300. CLOUSE K, Blevins M, Lindegren ML, Yotebieng M, et al
    Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.
    PLoS One. 2017;12:e0171384.
    PubMed     Text format     Abstract available


  301. MONTANE E, Barriocanal AM, Arellano AL, Valderrama A, et al
    Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae(R) in adults with or without latent TB infection: Safety and immunogenicity.
    PLoS One. 2017;12:e0171294.
    PubMed     Text format     Abstract available


  302. KUMAR NP, Moideen K, Viswanathan V, Sivakumar S, et al
    Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.
    PLoS One. 2017;12:e0184753.
    PubMed     Text format     Abstract available


  303. CUI JY, Liang HW, Pan XL, Li D, et al
    Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals.
    PLoS One. 2017;12:e0184113.
    PubMed     Text format     Abstract available


  304. BLANCO-GUILLOT F, Delgado-Sanchez G, Mongua-Rodriguez N, Cruz-Hervert P, et al
    Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0184675.
    PubMed     Text format     Abstract available


  305. BLOCH-INFANGER C, Battig V, Kremo J, Widmer AF, et al
    Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland.
    PLoS One. 2017;12:e0179537.
    PubMed     Text format     Abstract available


  306. SALAME FM, Ferreira MD, Belo MT, Teixeira EG, et al
    Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care.
    PLoS One. 2017;12:e0184061.
    PubMed     Text format     Abstract available


  307. SENGHORE M, Otu J, Witney A, Gehre F, et al
    Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria.
    PLoS One. 2017;12:e0184510.
    PubMed     Text format     Abstract available


  308. ZHANG C, Ruan Y, Cheng J, Zhao F, et al
    Comparing yield and relative costs of WHO TB screening algorithms in selected risk groups among people aged 65 years and over in China, 2013.
    PLoS One. 2017;12:e0176581.
    PubMed     Text format     Abstract available


  309. ABONGOMERA C, Ritmeijer K, Vogt F, Buyze J, et al
    Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.
    PLoS One. 2017;12:e0178996.
    PubMed     Text format     Abstract available


  310. TAVARES AM, Fronteira I, Couto I, Machado D, et al
    HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality.
    PLoS One. 2017;12:e0185526.
    PubMed     Text format     Abstract available


  311. LARSON EC, Novis CL, Martins LJ, Macedo AB, et al
    Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.
    PLoS One. 2017;12:e0185162.
    PubMed     Text format     Abstract available


  312. BONADONNA LV, Saunders MJ, Zegarra R, Evans C, et al
    Why wait? The social determinants underlying tuberculosis diagnostic delay.
    PLoS One. 2017;12:e0185018.
    PubMed     Text format     Abstract available


  313. MUSA BM, Adamu AL, Galadanci NA, Zubayr B, et al
    Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0185105.
    PubMed     Text format     Abstract available


  314. SHIM EJ, Lee KM, Kim EJ, Kim HG, et al
    CT pattern analysis of necrotizing and nonnecrotizing lymph nodes in Kikuchi disease.
    PLoS One. 2017;12:e0181169.
    PubMed     Text format     Abstract available


  315. SHIN HJ, Kim TO, Oh HJ, Park HY, et al
    Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: A propensity score matching analysis.
    PLoS One. 2017;12:e0181887.
    PubMed     Text format     Abstract available


  316. LETH C, Varadharajan A, Mester P, Fischaleck M, et al
    Matrixlysis, an improved sample preparation method for recovery of Mycobacteria from animal tissue material.
    PLoS One. 2017;12:e0181157.
    PubMed     Text format     Abstract available


  317. EMUKULE GO, Spreeuwenberg P, Chaves SS, Mott JA, et al
    Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.
    PLoS One. 2017;12:e0180890.
    PubMed     Text format     Abstract available


  318. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Text format     Abstract available


  319. TYLER AD, Randell E, Baikie M, Antonation K, et al
    Application of whole genome sequence analysis to the study of Mycobacterium tuberculosis in Nunavut, Canada.
    PLoS One. 2017;12:e0185656.
    PubMed     Text format     Abstract available


  320. MEKONNEN E, Bekele E
    An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1.
    PLoS One. 2017;12:e0184931.
    PubMed     Text format     Abstract available


  321. YU EA, John SH, Tablante EC, King CA, et al
    Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status.
    PLoS One. 2017;12:e0185640.
    PubMed     Text format     Abstract available


  322. BOIREAU C, Dufour B, Praud A
    The importance of communication in promoting voluntary participation in an experimental trial: A qualitative study based on the assessment of the gamma-interferon test for the diagnosis of bovine tuberculosis in France.
    PLoS One. 2017;12:e0185799.
    PubMed     Text format     Abstract available


  323. WANG X, Jiang H, Wang X, Liu H, et al
    ESMPE: A combined strategy for school tuberculosis prevention and control proposed by Dalian, China.
    PLoS One. 2017;12:e0185646.
    PubMed     Text format     Abstract available


  324. THERON A, Roth RL, Hoppe H, Parkinson C, et al
    Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform.
    PLoS One. 2017;12:e0185068.
    PubMed     Text format     Abstract available


  325. MAILANKODY S, Dangeti GV, Soundravally R, Joseph NM, et al
    Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
    PLoS One. 2017;12:e0181262.
    PubMed     Text format     Abstract available


  326. MICHEL AL, Lane EP, de Klerk-Lorist LM, Hofmeyr M, et al
    Experimental Mycobacterium bovis infection in three white rhinoceroses (Ceratotherium simum): Susceptibility, clinical and anatomical pathology.
    PLoS One. 2017;12:e0179943.
    PubMed     Text format     Abstract available


  327. ELLIS CK, Rice S, Maurer D, Stahl R, et al
    Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.
    PLoS One. 2017;12:e0179914.
    PubMed     Text format     Abstract available


  328. RICE JP, Seifert M, Moser KS, Rodwell TC, et al
    Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    PLoS One. 2017;12:e0186139.
    PubMed     Text format     Abstract available


  329. RENIERS G, Blom S, Lieber J, Herbst AJ, et al
    Tuberculosis mortality and the male survival deficit in rural South Africa: An observational community cohort study.
    PLoS One. 2017;12:e0185692.
    PubMed     Text format     Abstract available


  330. PATI S, Swain S, Metsemakers J, Knottnerus JA, et al
    Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India.
    PLoS One. 2017;12:e0183966.
    PubMed     Text format     Abstract available


  331. MINDU C, Lopez-Varela E, Alonso-Menendez Y, Mausse Y, et al
    Caretakers' perspectives of paediatric TB and implications for care-seeking behaviours in Southern Mozambique.
    PLoS One. 2017;12:e0182213.
    PubMed     Text format     Abstract available


  332. SCHECHTER MC, Buac K, Adekambi T, Cagle S, et al
    Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB.
    PLoS One. 2017;12:e0182587.
    PubMed     Text format     Abstract available


  333. RASOAHANITRALISOA R, Rakotosamimanana N, Stucki D, Sola C, et al
    Evaluation of spoligotyping, SNPs and customised MIRU-VNTR combination for genotyping Mycobacterium tuberculosis clinical isolates in Madagascar.
    PLoS One. 2017;12:e0186088.
    PubMed     Text format     Abstract available


  334. HIJIKATA M, Keicho N, Duc LV, Maeda S, et al
    Spoligotyping and whole-genome sequencing analysis of lineage 1 strains of Mycobacterium tuberculosis in Da Nang, Vietnam.
    PLoS One. 2017;12:e0186800.
    PubMed     Text format     Abstract available


  335. SCHNEEFELD M, Busche T, Geffers R, Kalinowski J, et al
    The transcriptional regulator LysG (Rv1985c) of Mycobacterium tuberculosis activates lysE (Rv1986) in a lysine-dependent manner.
    PLoS One. 2017;12:e0186505.
    PubMed     Text format     Abstract available


  336. CHAN SL, Chua APG, Aminkeng F, Chee CBE, et al
    Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
    PLoS One. 2017;12:e0186200.
    PubMed     Text format     Abstract available


  337. KAPWATA T, Morris N, Campbell A, Mthiyane T, et al
    Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa.
    PLoS One. 2017;12:e0181797.
    PubMed     Text format     Abstract available


  338. HSIAO CY, Chiu HY, Wang TS, Tsai TF, et al
    Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
    PLoS One. 2017;12:e0184178.
    PubMed     Text format     Abstract available


  339. BELLO G, Faragher B, Sanudi L, Namakhoma I, et al
    The effect of engaging unpaid informal providers on case detection and treatment initiation rates for TB and HIV in rural Malawi (Triage Plus): A cluster randomised health system intervention trial.
    PLoS One. 2017;12:e0183312.
    PubMed     Text format     Abstract available


  340. MUNOZ L, Gonzalez L, Soldevila L, Dorca J, et al
    QuantiFERON(R)-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.
    PLoS One. 2017;12:e0183258.
    PubMed     Text format     Abstract available


  341. HAVLICEK J, Rivera-Milla E, Slickers P, Andres S, et al
    An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs).
    PLoS One. 2017;12:e0183561.
    PubMed     Text format     Abstract available


  342. ALTET N, Latorre I, Jimenez-Fuentes MA, Maldonado J, et al
    Assessment of the influence of direct tobacco smoke on infection and active TB management.
    PLoS One. 2017;12:e0182998.
    PubMed     Text format     Abstract available


  343. AGIZEW T, Boyd R, Ndwapi N, Auld A, et al
    Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana.
    PLoS One. 2017;12:e0183237.
    PubMed     Text format     Abstract available


  344. CHENG AC, Yang KY, Chen NJ, Hsu TL, et al
    CLEC9A modulates macrophage-mediated neutrophil recruitment in response to heat-killed Mycobacterium tuberculosis H37Ra.
    PLoS One. 2017;12:e0186780.
    PubMed     Text format     Abstract available


  345. VINNARD C, Ravimohan S, Tamuhla N, Pasipanodya J, et al
    Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.
    PLoS One. 2017;12:e0187624.
    PubMed     Text format     Abstract available


  346. KAWATSU L, Uchimura K, Ohkado A
    Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.
    PLoS One. 2017;12:e0186588.
    PubMed     Text format     Abstract available


  347. CARCELEN M, Abascal E, Herranz M, Santanton S, et al
    Optimizing and accelerating the assignation of lineages in Mycobacterium tuberculosis using novel alternative single-tube assays.
    PLoS One. 2017;12:e0186956.
    PubMed     Text format     Abstract available


  348. NGABONZIZA JCS, Diallo AB, Tagliani E, Diarra B, et al
    Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    PLoS One. 2017;12:e0187211.
    PubMed     Text format     Abstract available


  349. XU L, Chen J, Innes AL, Li L, et al
    Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
    PLoS One. 2017;12:e0187076.
    PubMed     Text format     Abstract available


  350. CAMPBELL JR, Johnston JC, Sadatsafavi M, Cook VJ, et al
    Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.
    PLoS One. 2017;12:e0186778.
    PubMed     Text format     Abstract available


  351. FELDACKER C, Pintye J, Jacob S, Chung MH, et al
    Continuing professional development for medical, nursing, and midwifery cadres in Malawi, Tanzania and South Africa: A qualitative evaluation.
    PLoS One. 2017;12:e0186074.
    PubMed     Text format     Abstract available


  352. DANYUTTAPOLCHAI J, Kittimunkong S, Nateniyom S, Painujit S, et al
    Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
    PLoS One. 2017;12:e0184986.
    PubMed     Text format     Abstract available


  353. HERZMANN C, Ernst M, Lange C, Stenger S, et al
    Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals.
    PLoS One. 2017;12:e0187882.
    PubMed     Text format     Abstract available


  354. HE X, Cao M, Mahapatra T, Du X, et al
    Burden of tuberculosis in Xinjiang between 2011 and 2015: A surveillance data-based study.
    PLoS One. 2017;12:e0187592.
    PubMed     Text format     Abstract available


  355. ARMSTRONG-HOUGH M, Turimumahoro P, Meyer AJ, Ochom E, et al
    Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study.
    PLoS One. 2017;12:e0187145.
    PubMed     Text format     Abstract available


  356. ONYANGO DO, Yuen CM, Cain KP, Ngari F, et al
    Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.
    PLoS One. 2017;12:e0188235.
    PubMed     Text format     Abstract available


  357. HEMINGWAY C, Berk M, Anderson ST, Wright VJ, et al
    Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function.
    PLoS One. 2017;12:e0185973.
    PubMed     Text format     Abstract available


  358. PATEL S, Paulsen C, Heffernan C, Saunders D, et al
    Tuberculosis transmission in the Indigenous peoples of the Canadian prairies.
    PLoS One. 2017;12:e0188189.
    PubMed     Text format     Abstract available


  359. SHEWADE HD, Jeyashree K, Mahajan P, Shah AN, et al
    Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review.
    PLoS One. 2017;12:e0186697.
    PubMed     Text format     Abstract available


  360. RANZANI OT, Rodrigues LC, Waldman EA, Carvalho CRR, et al
    Estimating the impact of tuberculosis anatomical classification on treatment outcomes: A patient and surveillance perspective analysis.
    PLoS One. 2017;12:e0187585.
    PubMed     Text format     Abstract available


  361. ANDRES M, Gohring-Zwacka E, Fiebig L, Priwitzer M, et al
    Integration of molecular typing results into tuberculosis surveillance in Germany-A pilot study.
    PLoS One. 2017;12:e0188356.
    PubMed     Text format     Abstract available


  362. AL-RIFAI RH, Pearson F, Critchley JA, Abu-Raddad LJ, et al
    Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0187967.
    PubMed     Text format     Abstract available


  363. SOTGIU G, Falzon D, Hollo V, Kodmon C, et al
    Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014.
    PLoS One. 2017;12:e0186499.
    PubMed     Text format     Abstract available


  364. SON HJ, Sung H, Park SY, Kim T, et al
    Diagnostic performance of the (1-3)-beta-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
    PLoS One. 2017;12:e0188860.
    PubMed     Text format     Abstract available


  365. DOAN TN, Eisen DP, Rose MT, Slack A, et al
    Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    PLoS One. 2017;12:e0188631.
    PubMed     Text format     Abstract available


  366. MCMURTREY C, Harriff MJ, Swarbrick GM, Duncan A, et al
    T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.
    PLoS One. 2017;12:e0188288.
    PubMed     Text format     Abstract available


  367. SUN Y, Chen J, Li J, Xu Y, et al
    Novel approach based on one-tube nested PCR and a lateral flow strip for highly sensitive diagnosis of tuberculous meningitis.
    PLoS One. 2017;12:e0186985.
    PubMed     Text format     Abstract available


  368. LATORRE I, Minguez S, Carrascosa JM, Naves J, et al
    Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.
    PLoS One. 2017;12:e0189202.
    PubMed     Text format     Abstract available


  369. MAVE V, Kinikar A, Kagal A, Nimkar S, et al
    Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.
    PLoS One. 2017;12:e0189101.
    PubMed     Text format     Abstract available


  370. LAVANIA S, Anthwal D, Bhalla M, Singh N, et al
    Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears.
    PLoS One. 2017;12:e0189149.
    PubMed     Text format     Abstract available


  371. FLICK RJ, Munthali A, Simon K, Hosseinipour M, et al
    Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0189140.
    PubMed     Text format     Abstract available


  372. KIMUDA SG, Andia-Biraro I, Egesa M, Bagaya BS, et al
    Use of QuantiFERON(R)-TB Gold in-tube culture supernatants for measurement of antibody responses.
    PLoS One. 2017;12:e0188396.
    PubMed     Text format     Abstract available


  373. JONSSON J, Westman A, Bruchfeld J, Sturegard E, et al
    A borderline range for Quantiferon Gold In-Tube results.
    PLoS One. 2017;12:e0187313.
    PubMed     Text format     Abstract available


  374. SINGH B, Saqib M, Gupta A, Kumar P, et al
    Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
    PLoS One. 2017;12:e0189606.
    PubMed     Text format     Abstract available


  375. GRANDJEAN L, Gilman RH, Iwamoto T, Koser CU, et al
    Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru.
    PLoS One. 2017;12:e0189838.
    PubMed     Text format     Abstract available


  376. PITTALIS S, Piselli P, Contini S, Gualano G, et al
    Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.
    PLoS One. 2017;12:e0189425.
    PubMed     Text format     Abstract available


  377. BANDA HT, Thomson R, Mortimer K, Bello GAF, et al
    Community prevalence of chronic respiratory symptoms in rural Malawi: Implications for policy.
    PLoS One. 2017;12:e0188437.
    PubMed     Text format     Abstract available


  378. YU G, Ye B, Chen D, Zhong F, et al
    Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-gamma release assays for tuberculous pericarditis using pericardial tissue.
    PLoS One. 2017;12:e0188704.
    PubMed     Text format     Abstract available


  379. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    PubMed     Text format     Abstract available


  380. KIM Y, Kim BK, Choi HJ, Ryu SW, et al
    Lessons learned from continued TB outbreaks in a high school.
    PLoS One. 2017;12:e0188076.
    PubMed     Text format     Abstract available


  381. WAI PP, Shewade HD, Kyaw NTT, Kyaw KWY, et al
    Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths.
    PLoS One. 2017;12:e0187223.
    PubMed     Text format     Abstract available


    January 2016
  382. BASTOS HN, Osorio NS, Castro AG, Ramos A, et al
    A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0162797.
    PubMed     Text format     Abstract available


  383. FAGUNDEZ G, Perez-Freixo H, Eyene J, Momo JC, et al
    Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea.
    PLoS One. 2016;11:e0161995.
    PubMed     Text format     Abstract available


  384. AYUBI E, Doosti-Irani A, Sanjari Moghaddam A, Sani M, et al
    The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
    PLoS One. 2016;11:e0161983.
    PubMed     Text format     Abstract available


  385. MORISHITA F, Yadav RP, Eang MT, Saint S, et al
    Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia.
    PLoS One. 2016;11:e0162796.
    PubMed     Text format     Abstract available


  386. SSENGOOBA W, Respeito D, Mambuque E, Blanco S, et al
    Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?
    PLoS One. 2016;11:e0162833.
    PubMed     Text format     Abstract available


  387. MEHTA S, Das M, Laxmeshwar C, Jonckheere S, et al
    Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
    PLoS One. 2016;11:e0162138.
    PubMed     Text format     Abstract available


  388. AULD E, Lin J, Chang E, Byanyima P, et al
    HIV Infection Is Associated with Shortened Telomere Length in Ugandans with Suspected Tuberculosis.
    PLoS One. 2016;11:e0163153.
    PubMed     Text format     Abstract available


  389. FORST J, Brown TA
    Inability of 'Whole Genome Amplification' to Improve Success Rates for the Biomolecular Detection of Tuberculosis in Archaeological Samples.
    PLoS One. 2016;11:e0163031.
    PubMed     Text format     Abstract available


  390. KHALID R, Afzal M, Khurshid S, Paracha RZ, et al
    Fusion Molecules of Heat Shock Protein HSPX with Other Antigens of Mycobacterium tuberculosis Show High Potential in Serodiagnosis of Tuberculosis.
    PLoS One. 2016;11:e0163349.
    PubMed     Text format     Abstract available


  391. NARENDRAN G, Kavitha D, Karunaianantham R, Gil-Santana L, et al
    Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.
    PLoS One. 2016;11:e0163298.
    PubMed     Text format     Abstract available


  392. TURINAWE K, Vandebriel G, Lowrance DW, Uwinkindi F, et al
    Operating Characteristics of a Tuberculosis Screening Tool for People Living with HIV in Out-Patient HIV Care and Treatment Services, Rwanda.
    PLoS One. 2016;11:e0163462.
    PubMed     Text format     Abstract available


  393. WERGELAND I, Assmus J, Dyrhol-Riise AM
    Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.
    PLoS One. 2016;11:e0163848.
    PubMed     Text format     Abstract available


  394. STREATA I, Weiner J 3rd, Iannaconne M, McEwen G, et al
    The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0163662.
    PubMed     Text format     Abstract available


  395. CHANDA-KAPATA P, Kapata N, Masiye F, Maboshe M, et al
    Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia.
    PLoS One. 2016;11:e0163975.
    PubMed     Text format     Abstract available


  396. NASREEN S, Shokoohi M, Malvankar-Mehta MS
    Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0164034.
    PubMed     Text format     Abstract available


  397. CHOI HG, Choi S, Back YW, Park HS, et al
    Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential.
    PLoS One. 2016;11:e0164458.
    PubMed     Text format     Abstract available


  398. OMBURA IP, Onyango N, Odera S, Mutua F, et al
    Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya.
    PLoS One. 2016;11:e0163994.
    PubMed     Text format     Abstract available


  399. MASINI EO, Mansour O, Speer CE, Addona V, et al
    Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya.
    PLoS One. 2016;11:e0164172.
    PubMed     Text format     Abstract available


  400. LEE SH, Kwon AM, Yang HC, Lee SK, et al
    Longitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0164039.
    PubMed     Text format     Abstract available


  401. BLANKLEY S, Graham CM, Turner J, Berry MP, et al
    The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0162220.
    PubMed     Text format     Abstract available


  402. ZURCHER K, Zwahlen M, Ballif M, Rieder HL, et al
    Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.
    PLoS One. 2016;11:e0162575.
    PubMed     Text format     Abstract available


  403. SANAIE A, Mergenthaler C, Nasrat A, Seddiq MK, et al
    An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan.
    PLoS One. 2016;11:e0163813.
    PubMed     Text format     Abstract available


  404. GURJAV U, Outhred AC, Jelfs P, McCallum N, et al
    Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, Australia.
    PLoS One. 2016;11:e0163612.
    PubMed     Text format     Abstract available


  405. FLETCHER R, Jones JD, Shah NS
    Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments.
    PLoS One. 2016;11:e0164162.
    PubMed     Text format     Abstract available


  406. MCLAREN ZM, Schnippel K, Sharp A
    A Data-Driven Evaluation of the Stop TB Global Partnership Strategy of Targeting Key Populations at Greater Risk for Tuberculosis.
    PLoS One. 2016;11:e0163083.
    PubMed     Text format     Abstract available


  407. MATHEW B, Hobrath JV, Ross L, Connelly MC, et al
    Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.
    PLoS One. 2016;11:e0164100.
    PubMed     Text format     Abstract available


  408. JO YS, Park JH, Lee JK, Heo EY, et al
    Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications.
    PLoS One. 2016;11:e0164923.
    PubMed     Text format     Abstract available



  409. Correction: The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
    PLoS One. 2016;11:e0165143.
    PubMed     Text format     Abstract available


  410. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    PubMed     Text format     Abstract available


  411. OSPINA JE, Orcau A, Millet JP, Ros M, et al
    Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).
    PLoS One. 2016;11:e0164736.
    PubMed     Text format     Abstract available


  412. MCCALLUM AD, Nyirenda D, Lora W, Khoo SH, et al
    Perceptions of Research Bronchoscopy in Malawian Adults with Pulmonary Tuberculosis: A Cross-Sectional Study.
    PLoS One. 2016;11:e0165734.
    PubMed     Text format     Abstract available


  413. CHOI H, Chon HR, Kim K, Kim S, et al
    Clinical and Laboratory Differences between Lymphocyte- and Neutrophil-Predominant Pleural Tuberculosis.
    PLoS One. 2016;11:e0165428.
    PubMed     Text format     Abstract available


  414. ZHOU F, Xu X, Wu S, Cui X, et al
    Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients.
    PLoS One. 2016;11:e0165291.
    PubMed     Text format     Abstract available


  415. STREATA I, Weiner J Rd, Iannaccone M, McEwen G, et al
    Correction: The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0165853.
    PubMed     Text format     Abstract available


  416. PEREZ-PORCUNA TM, Pereira-da-Silva HD, Ascaso C, Malheiro A, et al
    Prevalence and Diagnosis of Latent Tuberculosis Infection in Young Children in the Absence of a Gold Standard.
    PLoS One. 2016;11:e0164181.
    PubMed     Text format     Abstract available


  417. ALVARO-MECA A, Diaz A, de Miguel Diez J, Resino R, et al
    Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era.
    PLoS One. 2016;11:e0165944.
    PubMed     Text format     Abstract available


  418. BERHANU R, Schnippel K, Mohr E, Hirasen K, et al
    Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study.
    PLoS One. 2016;11:e0164974.
    PubMed     Text format     Abstract available


  419. BEKKER A, Schaaf HS, Draper HR, Kriel M, et al
    Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape Town.
    PLoS One. 2016;11:e0164249.
    PubMed     Text format     Abstract available


  420. MOHAMMED S, Glennerster R, Khan AJ
    Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162944.
    PubMed     Text format     Abstract available


  421. SARKER M, Barua M, Guerra F, Saha A, et al
    Double Trouble: Prevalence and Factors Associated with Tuberculosis and Diabetes Comorbidity in Bangladesh.
    PLoS One. 2016;11:e0165396.
    PubMed     Text format     Abstract available


  422. LIM CH, Lin CH, Chen DY, Chen YM, et al
    One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
    PLoS One. 2016;11:e0166339.
    PubMed     Text format     Abstract available


  423. KARAT AS, Omar T, von Gottberg A, Tlali M, et al
    Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa.
    PLoS One. 2016;11:e0166158.
    PubMed     Text format     Abstract available


  424. CHUANG PH, Wu MH, Fan SY, Lin KY, et al
    Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014.
    PLoS One. 2016;11:e0165222.
    PubMed     Text format     Abstract available


  425. AIBANA O, Acharya X, Huang CC, Becerra MC, et al
    Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts.
    PLoS One. 2016;11:e0166333.
    PubMed     Text format     Abstract available


  426. LIU Z, Gao Y, Yang H, Bao H, et al
    Impact of Hypoxia on Drug Resistance and Growth Characteristics of Mycobacterium tuberculosis Clinical Isolates.
    PLoS One. 2016;11:e0166052.
    PubMed     Text format     Abstract available


  427. CHEN DY, Li JP, Chen YM, Liao TL, et al
    Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.
    PLoS One. 2016;11:e0166301.
    PubMed     Text format     Abstract available


  428. NOSOVA EY, Zimenkov DV, Khakhalina AA, Isakova AI, et al
    A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.
    PLoS One. 2016;11:e0167093.
    PubMed     Text format     Abstract available


  429. FATIMA R, Qadeer E, Yaqoob A, Haq MU, et al
    Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?
    PLoS One. 2016;11:e0165813.
    PubMed     Text format     Abstract available


  430. SMITH GC, Delahay RJ, McDonald RA, Budgey R, et al
    Model of Selective and Non-Selective Management of Badgers (Meles meles) to Control Bovine Tuberculosis in Badgers and Cattle.
    PLoS One. 2016;11:e0167206.
    PubMed     Text format     Abstract available


  431. BRONNER MURRISON L, Martinson N, Moloney RM, Msandiwa R, et al
    Tobacco Smoking and Tuberculosis among Men Living with HIV in Johannesburg, South Africa: A Case-Control Study.
    PLoS One. 2016;11:e0167133.
    PubMed     Text format     Abstract available


  432. NIETO R LM, Mehaffy C, Creissen E, Troudt J, et al
    Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC.
    PLoS One. 2016;11:e0166807.
    PubMed     Text format     Abstract available


  433. NUGENT G, Yockney IJ, Whitford EJ, Cross ML, et al
    Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula).
    PLoS One. 2016;11:e0167144.
    PubMed     Text format     Abstract available


  434. MODI S, Cavanaugh JS, Shiraishi RW, Alexander HL, et al
    Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya.
    PLoS One. 2016;11:e0167685.
    PubMed     Text format     Abstract available


  435. JIANG F, Huang W, Wang Y, Tian P, et al
    Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0167342.
    PubMed     Text format     Abstract available


  436. GUERRINI V, Subbian S, Santucci P, Canaan S, et al
    Experimental Evolution of Mycobacterium tuberculosis in Human Macrophages Results in Low-Frequency Mutations Not Associated with Selective Advantage.
    PLoS One. 2016;11:e0167989.
    PubMed     Text format     Abstract available


  437. HUNDIE GB, Woldemeskel D, Gessesse A
    Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    PLoS One. 2016;11:e0169188.
    PubMed     Text format     Abstract available


  438. BAEZ-SALDANA R, Delgado-Sanchez G, Garcia-Garcia L, Cruz-Hervert LP, et al
    Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
    PLoS One. 2016;11:e0168955.
    PubMed     Text format     Abstract available


  439. YEH JJ, Wang YC, Lin CC, Lin CL, et al
    Association of Respiratory Tuberculosis with Incident Bone Fracture: Bridging the Tuberculosis Airway Infection and the Osteoporotic Bone.
    PLoS One. 2016;11:e0168673.
    PubMed     Text format     Abstract available


  440. LAHEY T, Laddy D, Hill K, Schaeffer J, et al
    Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    PLoS One. 2016;11:e0168521.
    PubMed     Text format     Abstract available


  441. ZHANG F, Xu C, Ning L, Hu F, et al
    Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.
    PLoS One. 2016;11:e0167109.
    PubMed     Text format     Abstract available


  442. CABRERA-GAYTAN DA, Niebla-Fuentes MD, Padilla-Velazquez R, Valle-Alvarado G, et al
    Association of Pulmonary Tuberculosis and HIV in the Mexican Institute of Social Security, 2006-2014.
    PLoS One. 2016;11:e0168559.
    PubMed     Text format     Abstract available


  443. SUN Q, Wei W, Sha W
    Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-gamma Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    PLoS One. 2016;11:e0166501.
    PubMed     Text format     Abstract available


  444. DEKHIL N, Meftahi N, Mhenni B, Ben Fraj S, et al
    MDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 Years.
    PLoS One. 2016;11:e0153983.
    PubMed     Text format     Abstract available


  445. KJAERGAARD J, Stensballe LG, Birk NM, Nissen TN, et al
    Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.
    PLoS One. 2016;11:e0154541.
    PubMed     Text format     Abstract available


  446. TAI MS, Sharma VK
    Role of Transcranial Doppler in the Evaluation of Vasculopathy in Tuberculous Meningitis.
    PLoS One. 2016;11:e0164266.
    PubMed     Text format     Abstract available


  447. BIAN S, Zhang Y, Zhang L, Shi X, et al
    Diagnostic Value of Interferon-gamma Release Assays on Pericardial Effusion for Diagnosis of Tuberculous Pericarditis.
    PLoS One. 2016;11:e0165008.
    PubMed     Text format     Abstract available


  448. WEI W, Wei-Sheng Z, Ahan A, Ci Y, et al
    The Characteristics of TB Epidemic and TB/HIV Co-Infection Epidemic: A 2007-2013 Retrospective Study in Urumqi, Xinjiang Province, China.
    PLoS One. 2016;11:e0164947.
    PubMed     Text format     Abstract available


  449. MENG Q, Sayin I, Canaday DH, Mayanja-Kizza H, et al
    Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
    PLoS One. 2016;11:e0166954.
    PubMed     Text format     Abstract available


  450. HESLOP R, Bojang AL, Jarju S, Mendy J, et al
    Changes in Host Cytokine Patterns of TB Patients with Different Bacterial Loads Detected Using 16S rRNA Analysis.
    PLoS One. 2016;11:e0168272.
    PubMed     Text format     Abstract available


  451. GILBERT JA, Shenoi SV, Moll AP, Friedland GH, et al
    Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa.
    PLoS One. 2016;11:e0165614.
    PubMed     Text format     Abstract available


  452. BROPHY JC, Hawkes MT, Mwinjiwa E, Mateyu G, et al
    Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.
    PLoS One. 2016;11:e0165772.
    PubMed     Text format     Abstract available


  453. KILALE AM, Ngadaya E, Muhumuza J, Kagaruki GB, et al
    Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania.
    PLoS One. 2016;11:e0153711.
    PubMed     Text format     Abstract available


  454. HANIFA Y, Fielding KL, Chihota VN, Adonis L, et al
    Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa.
    PLoS One. 2016;11:e0156866.
    PubMed     Text format     Abstract available


  455. VELEN K, Lewis JJ, Charalambous S, Page-Shipp L, et al
    Household HIV Testing Uptake among Contacts of TB Patients in South Africa.
    PLoS One. 2016;11:e0155688.
    PubMed     Text format     Abstract available


  456. MEGHJI J, Simpson H, Squire SB, Mortimer K, et al
    A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.
    PLoS One. 2016;11:e0161176.
    PubMed     Text format     Abstract available


  457. SHENAI S, Ronacher K, Malherbe S, Stanley K, et al
    Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
    PLoS One. 2016;11:e0160062.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: